Arkolith/Insider Trading/NAGE/Form 4

Pamir Ozan

Chief Financial OfficerNiagen Bioscience, Inc. (NAGE) · full profile →Form 4 · filed Nov 17, 2025
Net Buying
Open-Market Buys
$46K
Open-Market Sells
$0
Net Open-Market Flow
$46K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2025Buy(P)4K$6.81$30K7K
Nov 14, 2025Buy(P)2K$6.85$15K2K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001834681-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML